Clinical efficacy of amniotic membrane with biphasic calcium phosphate in guided tissue regeneration of intrabony defects- a randomized controlled clinical trial

Abstract Background The concept of periodontal regeneration has been revolutionised since the introduction of growth factors and bioactive bone substitutes which ensures optimal regeneration of the diseased periodontium. The aim of the present study was to evaluate the efficacy of Amniotic membrane ...

Full description

Bibliographic Details
Main Authors: Nivedha Venkatesan, Vamsi Lavu, S. K. Balaji
Format: Article
Language:English
Published: American Association for the Advancement of Science (AAAS) 2021-05-01
Series:Biomaterials Research
Subjects:
Online Access:https://doi.org/10.1186/s40824-021-00217-7
_version_ 1797288660071088128
author Nivedha Venkatesan
Vamsi Lavu
S. K. Balaji
author_facet Nivedha Venkatesan
Vamsi Lavu
S. K. Balaji
author_sort Nivedha Venkatesan
collection DOAJ
description Abstract Background The concept of periodontal regeneration has been revolutionised since the introduction of growth factors and bioactive bone substitutes which ensures optimal regeneration of the diseased periodontium. The aim of the present study was to evaluate the efficacy of Amniotic membrane + Biphasic Calcium phosphate as compared to Collagen membrane + Biphasic Calcium phosphate for the management of periodontal intrabony defects. Methods 50 systemically healthy patients with localised moderate to severe periodontitis, sites which had a Probing Pocket Depth (PPD) ≥ 6 mm and an intrabony component of ≥ 3 mm as detected on Intra oral periapical radiographs (IOPAR) and bone sounding were recruited based on specific inclusion and exclusion criteria. They were randomly allocated by computer generated tables to Collagen membrane + Biphasic Calcium phosphate and Amniotic membrane + Biphasic Calcium phosphate groups. The amount of bone fill and changes in Probing Pocket Depth, Clinical Attachment Level were measured at baseline and six months. Results The results of the present study showed a mean reduction in the PPD of 2.89 ± 0.69 mm in the Collagen membrane + Biphasic Calcium phosphate group and 2.95 ± 0.57 mm in the Amniotic membrane + Biphasic Calcium phosphate group and CAL gain of 2.60 ± 1.43 mm in Collagen membrane + Biphasic Calcium phosphate group 3.18 ± 1.13 mm in the Amniotic membrane + Biphasic Calcium phosphate group at 6 months follow-up with no statistical significance between the groups. In terms of Defect resolution, 98.62 ± 6.51 % was achieved in Collagen membrane + Biphasic Calcium phosphate group and 98.25 ± 7.21 % in Amniotic membrane + Biphasic Calcium phosphate group. Conclusions Within the limitations of the present study, it can be concluded that AM can be used as a barrier membrane, in conjunction with Biphasic calcium phosphate, and provides comparable results to Collagen membrane with Biphasic calcium phosphate when used in the management of periodontal intrabony defects.
first_indexed 2024-03-07T18:52:42Z
format Article
id doaj.art-bb1e037261b04884bf8692bf4d80815e
institution Directory Open Access Journal
issn 2055-7124
language English
last_indexed 2024-03-07T18:52:42Z
publishDate 2021-05-01
publisher American Association for the Advancement of Science (AAAS)
record_format Article
series Biomaterials Research
spelling doaj.art-bb1e037261b04884bf8692bf4d80815e2024-03-02T01:12:50ZengAmerican Association for the Advancement of Science (AAAS)Biomaterials Research2055-71242021-05-012511910.1186/s40824-021-00217-7Clinical efficacy of amniotic membrane with biphasic calcium phosphate in guided tissue regeneration of intrabony defects- a randomized controlled clinical trialNivedha Venkatesan0Vamsi Lavu1S. K. Balaji2Department of Periodontology, Sri Ramachandra Institute of Higher Education and ResearchDepartment of Periodontology, Sri Ramachandra Institute of Higher Education and ResearchDepartment of Periodontology, Sri Ramachandra Institute of Higher Education and ResearchAbstract Background The concept of periodontal regeneration has been revolutionised since the introduction of growth factors and bioactive bone substitutes which ensures optimal regeneration of the diseased periodontium. The aim of the present study was to evaluate the efficacy of Amniotic membrane + Biphasic Calcium phosphate as compared to Collagen membrane + Biphasic Calcium phosphate for the management of periodontal intrabony defects. Methods 50 systemically healthy patients with localised moderate to severe periodontitis, sites which had a Probing Pocket Depth (PPD) ≥ 6 mm and an intrabony component of ≥ 3 mm as detected on Intra oral periapical radiographs (IOPAR) and bone sounding were recruited based on specific inclusion and exclusion criteria. They were randomly allocated by computer generated tables to Collagen membrane + Biphasic Calcium phosphate and Amniotic membrane + Biphasic Calcium phosphate groups. The amount of bone fill and changes in Probing Pocket Depth, Clinical Attachment Level were measured at baseline and six months. Results The results of the present study showed a mean reduction in the PPD of 2.89 ± 0.69 mm in the Collagen membrane + Biphasic Calcium phosphate group and 2.95 ± 0.57 mm in the Amniotic membrane + Biphasic Calcium phosphate group and CAL gain of 2.60 ± 1.43 mm in Collagen membrane + Biphasic Calcium phosphate group 3.18 ± 1.13 mm in the Amniotic membrane + Biphasic Calcium phosphate group at 6 months follow-up with no statistical significance between the groups. In terms of Defect resolution, 98.62 ± 6.51 % was achieved in Collagen membrane + Biphasic Calcium phosphate group and 98.25 ± 7.21 % in Amniotic membrane + Biphasic Calcium phosphate group. Conclusions Within the limitations of the present study, it can be concluded that AM can be used as a barrier membrane, in conjunction with Biphasic calcium phosphate, and provides comparable results to Collagen membrane with Biphasic calcium phosphate when used in the management of periodontal intrabony defects.https://doi.org/10.1186/s40824-021-00217-7Alveolar bone lossAmniotic membraneChronic periodontitisGuided tissue regenerationRandomized Controlled Trial
spellingShingle Nivedha Venkatesan
Vamsi Lavu
S. K. Balaji
Clinical efficacy of amniotic membrane with biphasic calcium phosphate in guided tissue regeneration of intrabony defects- a randomized controlled clinical trial
Biomaterials Research
Alveolar bone loss
Amniotic membrane
Chronic periodontitis
Guided tissue regeneration
Randomized Controlled Trial
title Clinical efficacy of amniotic membrane with biphasic calcium phosphate in guided tissue regeneration of intrabony defects- a randomized controlled clinical trial
title_full Clinical efficacy of amniotic membrane with biphasic calcium phosphate in guided tissue regeneration of intrabony defects- a randomized controlled clinical trial
title_fullStr Clinical efficacy of amniotic membrane with biphasic calcium phosphate in guided tissue regeneration of intrabony defects- a randomized controlled clinical trial
title_full_unstemmed Clinical efficacy of amniotic membrane with biphasic calcium phosphate in guided tissue regeneration of intrabony defects- a randomized controlled clinical trial
title_short Clinical efficacy of amniotic membrane with biphasic calcium phosphate in guided tissue regeneration of intrabony defects- a randomized controlled clinical trial
title_sort clinical efficacy of amniotic membrane with biphasic calcium phosphate in guided tissue regeneration of intrabony defects a randomized controlled clinical trial
topic Alveolar bone loss
Amniotic membrane
Chronic periodontitis
Guided tissue regeneration
Randomized Controlled Trial
url https://doi.org/10.1186/s40824-021-00217-7
work_keys_str_mv AT nivedhavenkatesan clinicalefficacyofamnioticmembranewithbiphasiccalciumphosphateinguidedtissueregenerationofintrabonydefectsarandomizedcontrolledclinicaltrial
AT vamsilavu clinicalefficacyofamnioticmembranewithbiphasiccalciumphosphateinguidedtissueregenerationofintrabonydefectsarandomizedcontrolledclinicaltrial
AT skbalaji clinicalefficacyofamnioticmembranewithbiphasiccalciumphosphateinguidedtissueregenerationofintrabonydefectsarandomizedcontrolledclinicaltrial